TY - CHAP
T1 - Cellular and Molecular Mechanisms of Toxicity of Ingested Titanium Dioxide Nanomaterials
AU - Vieira, Adriana
AU - Gramacho, Ana
AU - Rolo, Dora
AU - Vital, Nádia
AU - Silva, Maria João
AU - Louro, Henriqueta
N1 - Funding: This work was funded by national funds through the FCT - Foundation for Science and Technology, I.P., under the project INGESTnano- PTDC/ SAU-PUB/29481/2017. Research co-funded by European Union Seventh Framework Programme (FP7/ 2007e2013) under the project NANoREG (A common European approach to the regulatory testing of nanomaterials), grant agreement 310584 and by UIDB/00009/2020; UIDP/00009/2020 (Centre for Toxicogenomics and Human Health – ToxOmics, Foundation for Science and Technology). NV holds a FCT PhD Scholarship grant (2020.07168.BD)
PY - 2022
Y1 - 2022
N2 - An exponential increase in products containing titanium dioxide nanomaterials (TiO2), in agriculture, food and feed industry, lead to increased oral exposure to these nanomaterials (NMs). Thus, the gastrointestinal tract (GIT) emerges as a possible route of exposure that may drive systemic exposure, if the intestinal barrier is surpassed. NMs have been suggested to produce adverse outcomes, such as genotoxic effects, that are associated with increased risk of cancer, leading to a concern for public health. However, to date, the differences in the physicochemical characteristics of the NMs studied and other variables in the test systems have generated contradictory results in the literature. Processes like human digestion may change the NMs characteristics, inducing unexpected toxic effects in the intestine. Using TiO2 as case-study, this chapter provides a review of the works addressing the interactions of NMs with biological systems in the context of intestinal tract and digestion processes, at cellular and molecular level. The knowledge gaps identified suggest that the incorporation of a simulated digestion process for in vitro studies has the potential to improve the model for elucidating key events elicited by these NMs, advancing the nanosafety studies towards the development of an adverse outcome pathway for intestinal effects.
AB - An exponential increase in products containing titanium dioxide nanomaterials (TiO2), in agriculture, food and feed industry, lead to increased oral exposure to these nanomaterials (NMs). Thus, the gastrointestinal tract (GIT) emerges as a possible route of exposure that may drive systemic exposure, if the intestinal barrier is surpassed. NMs have been suggested to produce adverse outcomes, such as genotoxic effects, that are associated with increased risk of cancer, leading to a concern for public health. However, to date, the differences in the physicochemical characteristics of the NMs studied and other variables in the test systems have generated contradictory results in the literature. Processes like human digestion may change the NMs characteristics, inducing unexpected toxic effects in the intestine. Using TiO2 as case-study, this chapter provides a review of the works addressing the interactions of NMs with biological systems in the context of intestinal tract and digestion processes, at cellular and molecular level. The knowledge gaps identified suggest that the incorporation of a simulated digestion process for in vitro studies has the potential to improve the model for elucidating key events elicited by these NMs, advancing the nanosafety studies towards the development of an adverse outcome pathway for intestinal effects.
KW - Ingestion
KW - Intestinal cells
KW - Nanomaterials
KW - Nanotoxicology
KW - Titanium dioxide
UR - http://www.scopus.com/inward/record.url?scp=85130767742&partnerID=8YFLogxK
U2 - 10.1007/978-3-030-88071-2_10
DO - 10.1007/978-3-030-88071-2_10
M3 - Chapter
C2 - 35583647
AN - SCOPUS:85130767742
VL - 1357
T3 - Advances in Experimental Medicine and Biology
SP - 225
EP - 257
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -